Global Pediatric Vaccines Market Analysis & Opportunity Outlook 2021

Global Pediatric Vaccines Market Analysis & Opportunity Outlook 2021

Buy Now
Report ID: 120 | Published On: Jan 30, 2023

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.


In The News


Pediatric Vaccines Market Overview

Pediatric vaccines work as a protective shield for infants, children and adolescents (age ranging from 0-18 years) against various fatal diseases such as influenza, diphtheria, hepatitis, meningococcal and pneumococcal diseases etc.

The global pediatric vaccine market was valued at USD 24 Billion in 2015 and is anticipated to exhibit a robust compound annual growth rate (CAGR) of 10.6% over the forecast period. Regionally, the global pediatric vaccine market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific and Rest of World. Asia-Pacific is projected to witness the highest growth rate in pediatric vaccines market in coming 5-6 years.


Market Size and Forecast

North America holds the top rank in pediatric vaccines market in the world. The pediatric vaccines market in North America is sparked by higher spending by the Federal government on healthcare industry. The U.S. and Canada are two major markets of pediatric vaccines in North America.Europe pediatric vaccines market is also propelled by larger government spending on development of medical and pharmaceutical industry. The market in major European countries such as Germany, Italy, France, Spain and U.K. is boosted from the funding allotted by public healthcare services such as NHS (Nation Healthcare Service). 

Asia-Pacific paediatric vaccines market is expected to get escalated by increasing initiatives of World Health organisation (WHO) in countries such as India, China and Japan. In addition to that, Asia-Pacific pediatric market is also likely to get fostered from strengthening economic growth of major Asian countries in future.

Get more information on this report: Download Sample PDF


Market Segmentation

  • By Types

On the basis of technology, the global paediatric market is segmented into synthetic vaccines, dendritic cells vaccines, toxoid vaccines, live attenuated vaccines, inactivated vaccines, subunit vaccines and recombinant vector vaccines.

  • By Diseases

Based on disease the global paediatric market is segmented into cancer, Hepatitis A, Hepatitis B, Influenza, Polio, Rotavirus, Tetanus, allergy, infectious disease and other diseases.

The study further analysis the Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).


button
Get more information on this report: Request Sample PDF

Growth Drivers and challenges

Expanding government and private spending on development of pediatric and other vaccines is a major factor which is believed to foster the growth of global paediatric market in coming 5-6 years.However, limited or no access to healthcare services in developing/under-developed countries, low healthcare spending, and lower pediatric vaccination coverage etc. are some of the challenges which might hamper the growth of global paediatric vaccines market in future.


Key Players

The global pediatric vaccines market includes some of the top players such as Pfize, Merck, Sanofi Pasteur, Sinovac Biotech, Bio Med, Valeant Pharmaceuticals, Dynavax Technologies etc.                                                         


Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample